Do you think CAPR will decline further?

Capricor Therapeutics Inc (CAPR) is likely to experience continued pressure in the near term. Here's a detailed analysis to support this view:

1. Current Bearish Trend: CAPR's stock is currently in a bearish trend with a 25-day duration. The probability of this trend continuing is 83%, with a clearer trend expected to persist for at least 24 days.
2. Analyst Sentiment: While analysts have set a high 12-month price target of $31.67, with a high estimate of $77.00, the current price at $16.84 reflects a significant gap to the average target. This suggests that analysts expect a potential upside, but the stock's recent performance does not yet align with these expectations.

CAPR Trend

3. Market Reaction to News: The recent decline of 14.26% in a single trading session indicates a strong negative reaction to recent news or events. Without positive catalysts, it's common for stocks to continue under pressure until there is a change in fundamentals or investor sentiment.

CAPR Trend

4. Financial Health Concerns: Capricor has reported significant net losses in the recent quarters, with a trend of increasing losses over time. This financial health concerns could lead to further declines if not addressed.

CAPR Operating Income, Net Income...

In conclusion, the combination of a bearish trend, analyst expectations, recent price action, and financial health indicators suggest that CAPR may continue to decline further in the absence of positive news or changes in investor sentiment.